BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30334342)

  • 1. Vasopressin augments TNBS-induced colitis through enteric neuronal V
    Dou D; Chen L; Di H; Song Z; Li S; Bu X; Dai Q; Wang S; Li JX; Zhu X; Jing H
    Neurogastroenterol Motil; 2019 Feb; 31(2):e13493. PubMed ID: 30334342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD.
    Ferrier L; Serradeil-Le Gal C; Schulte AM; Vasina V; Gaultier E; Schroedel S; Ursino MG; Chaumaz G; Pascal M; De Ponti F; Bueno L
    Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1298-307. PubMed ID: 20864658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats.
    Paiotti AP; Ribeiro DA; Silva RM; Marchi P; Oshima CT; Neto RA; Miszputen SJ; Franco M
    J Mol Histol; 2012 Jun; 43(3):307-17. PubMed ID: 22426941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones.
    Gouzénes L; Sabatier N; Richard P; Moos FC; Dayanithi G
    J Physiol; 1999 Jun; 517 ( Pt 3)(Pt 3):771-9. PubMed ID: 10358117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4
    Dou D; Ji Y; Zheng J; Li J; Zhu X; Tang S; Wang H; Li Q; Jing H
    Dig Dis Sci; 2022 Aug; 67(8):3683-3692. PubMed ID: 34751838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine vasopressin, via activation of post-junctional V1 receptors, induces contractile effects in mouse distal colon.
    Mastropaolo M; Zizzo MG; Auteri M; Mulè F; Serio R
    Regul Pept; 2013 Nov; 187():29-34. PubMed ID: 24185041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
    Reymond-Marron I; Tribollet E; Raggenbass M
    Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin in human inflammatory bowel disease: comparison to rat trinitrobenzenesulphonic acid-induced colitis.
    McCartney SA; Ballinger AB; Vojnovic I; Farthing MJ; Warner TD
    Life Sci; 2002 Sep; 71(16):1893-904. PubMed ID: 12175704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin V1a and V1b receptors: from molecules to physiological systems.
    Koshimizu TA; Nakamura K; Egashira N; Hiroyama M; Nonoguchi H; Tanoue A
    Physiol Rev; 2012 Oct; 92(4):1813-64. PubMed ID: 23073632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextran sodium sulphate-induced colitis perturbs muscarinic cholinergic control of colonic epithelial ion transport.
    Sayer B; Lu J; Green C; Söderholm JD; Akhtar M; McKay DM
    Br J Pharmacol; 2002 Apr; 135(7):1794-800. PubMed ID: 11934821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Methyl-D-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat.
    Varga G; Erces D; Fazekas B; Fülöp M; Kovács T; Kaszaki J; Fülöp F; Vécsei L; Boros M
    Neurogastroenterol Motil; 2010 Feb; 22(2):217-25, e68. PubMed ID: 19735360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
    Oshikawa S; Tanoue A; Koshimizu TA; Kitagawa Y; Tsujimoto G
    Mol Pharmacol; 2004 Mar; 65(3):623-9. PubMed ID: 14978240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting eotaxin-1 and CCR3 receptor alleviates enteric neuropathy and colonic dysfunction in TNBS-induced colitis in guinea pigs.
    Filippone RT; Robinson AM; Jovanovska V; Stavely R; Apostolopoulos V; Bornstein JC; Nurgali K
    Neurogastroenterol Motil; 2018 Nov; 30(11):e13391. PubMed ID: 29968270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.
    Serradeil-Le Gal C; Wagnon J; Valette G; Garcia G; Pascal M; Maffrand JP; Le Fur G
    Prog Brain Res; 2002; 139():197-210. PubMed ID: 12436936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats.
    Onori L; Aggio A; D'Alo' S; Muzi P; Cifone MG; Mellillo G; Ciccocioppo R; Taddei G; Frieri G; Latella G
    World J Gastroenterol; 2005 Sep; 11(36):5677-84. PubMed ID: 16237764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic vasoconstrictor regulation of mouse colonic submucosal arterioles is altered in experimental colitis.
    Lomax AE; O'Reilly M; Neshat S; Vanner SJ
    J Physiol; 2007 Sep; 583(Pt 2):719-30. PubMed ID: 17615098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBS-induced colitis.
    Robinson AM; Sakkal S; Park A; Jovanovska V; Payne N; Carbone SE; Miller S; Bornstein JC; Bernard C; Boyd R; Nurgali K
    Am J Physiol Gastrointest Liver Physiol; 2014 Dec; 307(11):G1115-29. PubMed ID: 25301186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model.
    Sutton TL; Zhao A; Madden KB; Elfrey JE; Tuft BA; Sullivan CA; Urban JF; Shea-Donohue T
    Infect Immun; 2008 Oct; 76(10):4772-82. PubMed ID: 18644879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic migrating motor complexes are inhibited in acute tri-nitro benzene sulphonic acid colitis.
    Hofma BR; Wardill HR; Mavrangelos C; Campaniello MA; Dimasi D; Bowen JM; Smid SD; Bonder CS; Beckett EA; Hughes PA
    PLoS One; 2018; 13(6):e0199394. PubMed ID: 29933379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
    Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):63-9. PubMed ID: 9459574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.